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Citrate forms soluble complexes with the calcium ion and a
significant part of the 20 to 25% binding of this cation in urine
has been attributed to the presence of this anion [1, 2]. It has
also been shown that citrate is significantly adsorbed on calcium
oxalate monohydrate (COM) [3, 4] and retards the rate of
mineralization of this stone-forming mineral, as well as that of
the calcium phosphates [5, 61. On the basis of such studies, it
has been suggested that potassium citrate is beneficial in the
treatment of stone disease [7]. In our laboratory, with the
development of a protected calcium electrode [8], it is now
possible to investigate, in whole urine experiments, the inhibi-
tory effect of urinary macromolecules using a highly reproduc-
ible constant composition method [9]. To be able to analyze the
kinetic results, the rapid determination of citrate ion in whole
urine, before bacterial decomposition sets in, is essential.
Normally, three different types of citrate analyses have been
used: (1) by converting to pentabromoacetone which is deter-
mined colorimetrically [101; (2) by isotachophoresis [11]; and (3)
using citrate lyase [12, 13]. The use of the citrate lyase enzyme
is probably one of the most widely used methods, but all require
relatively long periods to complete the analyses. Moreover,
many studies of citrate effects have been made in simulated
synthetic solutions and there is a pressing need, in the light of
our recent mineralization studies in whole urine, to be able to
estimate citrate rapidly in this medium. With the development
of a fast ion chromatographic method, the citrate analyses
described in this paper have been made in as little as 11 mm
without any pretreatment.
A Dionex QIC analyzer (Sunnyvale, California, USA) with
conductometric detector was used at a temperature of 22 1°C.
All chemicals were Analyzed Reagent Grade (Baker Chemical
Co., Phihipsburg, New Jersey, USA or Fisher Scientific Co.,
Fairlawn, New Jersey, USA) and citrate lyase was Sigma
Chemical Company, lot number 53F .05 15 (St. Louis, Missouri,
USA). The conductivity detection mode was adjusted for three
or ten microsiemens cm', and peak heights were measured
with an Omniscribe chart recorder (Houston Instruments, Aus-
tin, Texas, USA). A Dionex AG3 P/N 030986 anion exchange
analytical pre-column was used which, unlike conventional
suppressor columns, employed a Dionex anion fibre suppressor
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Table 1. Citrate in urines from ten normal subjects, as determined by
citrate lyase and IC methods
Citrate lyase Ion chromatography
Urine sample x, mM y, mM
1 5.37 5.33
2 1.47 1.40
3 2.29 2.30
4 4.10 4.13
5 2.06 2,10
6 2.27 2.23
7 1.05 1.07
8 2.10 2.13
9 1.44 1.53
10 2.27 2.31
Regression equation, y = x — 0.0017: r = 0.9992.
Table 2. Retention times for some urinary anions
Retention time
Anion mm
Chloride 1.4
Phosphate 1.5
Sulfate 1.7
Oxalate 1.7
Lactate 1.8
Nitrate 1.9
Thiosulfate 3.5
Citrate 7.8
P/N 035691, enabling continuous operation without regenera-
tion. Sodium carbonate (8 mM) was used isocratically at a flow
rate of 2.2 mlJmin1, and the regenerant was 100 m sulfuric
acid at a flow rate of 2.8 ml/min1. Urine samples, obtained
from six normal male subjects, were used, both fresh and after
freezing. Samples kept frozen for 8 days showed no change in
the citrate analyses. For urine kept at 4°C, however, the
observed significant decreases in citrate content [14] are due to
bacterial decomposition.
HPIC analyses were made by injecting 100 tl of diluted
urines (50 or 100-fold dilution with triple distilled deionized
water) into the injection port after filtering through 0.22 pm
pore size Mihipore filters. Citrate peak heights in the urine
samples were compared with standard citrate solutions, which
were prepared using reagent grade sodium citrate together with
similar amounts of sulfate, phosphate, and chloride as those in
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Table 3. Effect of different levels of chloride, phosphate, and sulfate on citrate analysis in aqueous solution
Initial citrate
mM
Added chloride
mM
Added phosphateM Added sulfatemM Analyzed citratemM CV%(N=5)
0.0520 1.5 0.21 0.21 0.0523 0.0006 1.15
0.0520 5.0 0.80 0.80 0.0523 0.0005 0.96
0.1041 3.0 0.40 0.40 0.1042 0.0007 0.70
0.1041 7.0 0.40 0.40 0.1036 0.0008 0.80
the urine samples. Typically, for instance, for the comparison
of citrate peaks in 1% urine, the 0.1 m citrate standard
solution, 1.5 m in sodium chloride, contained 0.2 m each of
sulfate and dihydrogenphosphate. Linearity of the standard
plots of peak height, y, against citrate concentration, x, was
very good up to 0.25 m, the highest concentration investi-
gated. The correlation coefficient (r) was 0.9999, and the
regression equation was y = S9.Tlx — 0.066. For comparison of
the HPIC determinations, we used the citrate lyase method [15]
(citric acid assay kit, cat. #139076, Boehringer Mannheim,
Indianapolis, Indiana, USA), measuring the change in absorb-
ance at 340 nm using a double beam Varian CARY 210
spectrophotometer (Palo Alto, California, USA). The excellent
agreement between the citrate analytical methods for urine
samples from ten different subjects is seen in Table 1.
A typical chromatograph is shown in Figure 1A with an 8-mm
citrate retention time identical to that of the stndard citrate
solutions. Confirmation was obtained by treatmg the same
sample with citrate lyase before injecting into the column. The
chromatograph in Figure lB confirms the absence of citrate
peak. The small unassigned peak indicated by the arrow in
Figure 1A (preceeding the citrate elution peak, but clearly
separated from it) was the only one observed after the citrate
had been removed with citrate lyase (Fig. 1B). It was important
to use 8 m sodium carbonate eluent, however, since at higher
concentrations (10 mM) this small peak interfered with the
citrate peak. The first major peak in Figure 1 is due mainly to
chloride, phosphate, and sulfate. The close retention times of
these anions in Table 2 suggest that they will not interfere with
the citrate analysis. This is confirmed by the data presented in
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Table 4. Citrate analysis of urines with standard citrate addition
A
Urine citrate
mM
Added citrate
m
Analyzed citrate
mM
CVa
%
Recovery
%
0.50 0.30 0.295 (Ø01)b 3.4 98.3
2.20 0.30 0.310 (0.01) 3.2 103.3
4.20 0.30 0.290 (0.02) 6.9 96.7
a CV is coefficient of variation.
b Standard deviation shown in parentheses.
Five determinations made on each sample.
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Fig. 1A. Typical chromatogram of urine sample of normal subject.
Urine was diluted fiftyfold. B Chromatogram of the same sample after
treating with citrate lyase.
Table 3, which show that the citrate analytical results are
essentially unaffected by changes in concentration of these
anions.
a
The citrate recovery following standard addition of sodium
citrate to different urine samples containing three levels of
citrate is illustrated in Table 4. In these experiments, 0.5 ml of
urine together with 0.7 ml of 0.52 m sodium citrate was diluted
to 25 ml. After filtration, 100 p1 were injected into the column.
The mean recovery was 99.4%. Excellent precision was also
obtained in the citrate analyses of both fresh urines (0.98 mris,
CV 3.5%; 1.07 m, CV 3.2%; 2.06 m, CV 3.2%) and for urine
samples that had been frozen for 8 days before analysis (0.50
mM, CV 4.6%; 2.2 m, CV 1.7%, and 4.2 mi, CV 1.5%).
In conclusion, the high performance ion chromatographic
method described in this paper can be used to analyze urinary
citrate in less than 11 mm. The minimum amount of citrate that
can be detected using this chromatographic method is 0.05 mM.
Urine dilution factors ranging from 25 to 250 have been used
satisfactorily with CV values less than 5%. Although this
detection limit is higher than those reported for some other
analytical methods, rapid determinations of citrate may be
made at the relatively high levels frequently found in both
normal and stone-forming urine [16, 17]. More importantly, the
analyses can be made using the same samples and similar HPIC
procedures currently used in our laboratory for oxalate, phos-
phate, and sulfate determinations.
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